Literature DB >> 12023799

Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.

Robert N Jorissen1, Herbert R Treutlein, V Chandana Epa, Antony W Burgess.   

Abstract

Signaling from the epidermal growth factor (EGF) receptor is triggered by the binding of ligands such as EGF or transforming growth factor alpha (TGF-alpha) and subsequent receptor dimerization. An understanding of these processes has been hindered by the lack of structural information about the ligand-bound, dimerized EGF receptor. Using an NMR-derived structure of EGF and a homology model of the major ligand binding domain of the EGF receptor and experimental data, we modeled the binding of EGF to this EGF receptor fragment. In this low resolution model of the complex, EGF sits across the second face of the EGF receptor L2 domain and EGF residues 10-16, 36-37, 40-47 bind to this face. The structural model is largely consistent with previously published NMR data describing the residues of TGF-alpha which interact strongly with the EGF receptor. Other EGF residues implicated in receptor binding are accounted by our proposal that the ligand binding is a two-step process with the EGF binding to at least one other site of the receptor. This three-dimensional model is expected to be useful in the design of ligand-based antagonists of the receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023799     DOI: 10.1080/07391102.2002.10506800

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  3 in total

1.  A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.

Authors:  Edwin M Posadas; Meghan S Liel; Virginia Kwitkowski; Lori Minasian; Andrew K Godwin; Mahrukh M Hussain; Virginia Espina; Bradford J Wood; Seth M Steinberg; Elise C Kohn
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

2.  The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.

Authors:  Melissa J Cudmore; Peter W Hewett; Shakil Ahmad; Ke-Qing Wang; Meng Cai; Bahjat Al-Ani; Takeshi Fujisawa; Bin Ma; Samir Sissaoui; Wenda Ramma; Mark R Miller; David E Newby; Yuchun Gu; Bernhard Barleon; Herbert Weich; Asif Ahmed
Journal:  Nat Commun       Date:  2012-07-24       Impact factor: 14.919

3.  VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.

Authors:  Joy Sarkar; Yuncin Luo; Qiang Zhou; Evguenia Ivakhnitskaia; Daniel Lara; Eitan Katz; Michael G Sun; Victor Guaiquil; Mark Rosenblatt
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.